SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

CREATE AN ACCOUNT FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

CREATE ACCOUNT

ALREADY HAVE AN ACCOUNT?

Magnartis Finance & Investment Limited

  • LOGIN
  • Home
  • About
    • About Us
    • Management Team
    • Directors
  • Services
    • Stockbroking
    • Portfolio Management
    • Corporate Finance
    • Advisory Services
  • Projects
  • Download
  • Contact
  • Open an account
  • Home
  • Pfizer, Merck strike deal to develop cancer tumor treatment
  • Capital Market News
  • Pfizer, Merck strike deal to develop cancer tumor treatment
 

Pfizer, Merck strike deal to develop cancer tumor treatment

Pfizer, Merck strike deal to develop cancer tumor treatment

by magna / Monday, 17 November 2014 / Published in Capital Market News

Germany’s Merck will get $850 million upfront to work on the product, but Pfizer downgrades its 2014 EPS view as a result of the transaction.

Source : MarketWatchCom

About magna

What you can read next

Profit Taking: NSE Market Capitalistion Sheds N141bn
Indices Rise As Bullish Transactions Persist On The Exchange
Jaiz Bank assures shareholders of improved returns

Market Capitalization

[visualizer id="161"]

Newsletter Subscription


 

About Us

Magnartis Finance & Investment Ltd (“Magnartis”) is a Dealing Member of The Nigerian Stock Exchange with expertise in Stockbroking and Trade Execution Services.

Download

  • FGN Savings Bond Subscription Form
  • Mandate For Ebonus
  • Cscs Clients Authorization Form For Change Of Bank
  • Cscs Client Bank Update Form
  • Account Opening Form KYC

Research

  • Daily Price List
  • Daily Market Summary
  • Weekly Market Summary
  • Special Reports

Contact Info

16, Boyle Street, Onikan, Lagos, Nigeria

Office Number:
01-4538066

E-mail:
info@magnartis.com

  • GET SOCIAL

© 2014 Magnartis Finance & Investment Limited. All Right Reserved

TOP